Real-time enrollment status for this thrombasthenia clinical trial
Current Status
Recruiting
Checked: November 15, 2026 at 2:54 PM UTC
| NCT Number | NCT07935356 |
| Recruiting Status | Recruiting |
| Condition | Thrombasthenia |
| Phase | PHASE3 |
| Target Enrollment | 76 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Hemab ApS |
| Last Updated on CT.gov | November 13, 2026 (2 days ago) |
As of November 15, 2026: Clinical trial NCT07935356 is currently recruiting participants. This phase3 study for thrombasthenia is actively seeking new participants at 9 locations across the United States. The study is sponsored by Hemab ApS. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07935356 is actively recruiting participants as of November 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07935356 was last updated 2 days ago (November 13, 2026). HelloStudys verifies this status automatically.